Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity | Zendy

Ali Aminian | Zendy; Alexander Zajichek | Zendy; David Arterburn | Zendy; Kathy Wolski | Zendy; Stacy A. Brethauer | Zendy; Philip R. Schauer | Zendy; Michael W. Kattan | Zendy; Steven E. Nissen | Zendy

Open Access

Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity

Author(s) -

Ali Aminian,

Alexander Zajichek,

David Arterburn,

Kathy Wolski,

Stacy A. Brethauer,

Philip R. Schauer,

Michael W. Kattan,

Steven E. Nissen

Publication year - 2019

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2019.14231

Subject(s) - medicine , mace , body mass index , type 2 diabetes , interquartile range , diabetes mellitus , glycated hemoglobin , myocardial infarction , stroke (engine) , obesity , surgery , percutaneous coronary intervention , endocrinology , mechanical engineering , engineering

Although metabolic surgery (defined as procedures that influence metabolism by inducing weight loss and altering gastrointestinal physiology) significantly improves cardiometabolic risk factors, the effect on cardiovascular outcomes has been less well characterized.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research